European Notebook: Renewed Calls For German Pricing Law Changes, Spain Gauges The Value Of Innovation
Executive Summary
German health insurers run a cash surplus in the first quarter; Celesio CEO dismissed; Bayer celebrates 150 years; Spain wants to evaluate value for drug pricing; France's drug spend declines in 2012, and more.